Search & Filter

The flu jab is associated with a reduced risk of hospitalisation in patients with heart failure, according to research presented  in a late breaking trial session at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure.

The World Health Organization (WHO) has issued a warning regarding the global spread of the Zika virus which causes microcephaly after the first detection of it in Cape Verde, Africa.

A UK-wide study looking at the prescribing of anti-osteoporotic drugs to people aged 50 years or above has found that, since 2006, AOD prescription rates for women have decreased and rates for men have levelled off, despite a growing elderly population and associated fracture risks for osteoporosis.

New research published today by Age UK reveals that the number of people in their 80s and over who provide care for a loved one has risen by almost 39% in the past seven years to 417,000.

Cancer Research has announced a £4 million investment to expand the UK's first ever national study collecting blood and tissue samples from patients who have died from cancer, in a bid to shed light on what happens during the final stages of the disease.

The Nuffield Trust has published a new report which suggests that developing the existing non-medical workforce is vital for trusts to meet the changing needs of patients.

Scientists from KU Leuven, Belgium, have presented a new therapeutic approach that may make it possible for HIV patients to (temporarily) stop taking their medication.

Most GPs believe mental health services for young people are inadequate, with almost 9 in 10 fearing that children or teenagers may come to harm while waiting for specialist treatment, new research shows.

The Scottish Medicines Consortium (SMC) has approved the use of bevacizumab (Avastin) for the treatment of women with an advanced and incurable form of cervical cancer.

The British Society for Rheumatology (BSR) has  launched a report setting out a programme of work to enhance care for people with rare rheumatic and musculoskeletal conditions.

The British Society for Rheumatology (BSR) has launched a report setting out a programme of work to enhance care for people with rare rheumatic and musculoskeletal conditions.

Women in Scotland with an advanced and incurable form of cervical cancer could benefit from the targeted treatment Avastin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS. 

NICE has recommended adalimumab (Humira) for the treatment of active moderate to severe hidradenitis suppurativa (HS) in adult patients with an inadequate response to conventional systemic HS therapy, as per the marketing authorisation for adalimumab. Following this recommendation suitable patients in England and Wales should be able to access adalimumab on the NHS. 

Vifor Fresenius Medical Care Renal Pharma, a common company of Galenica and Fresenius Medical Care, and OPKO Health, have entered into a collaboration and license agreement for the development and commercialisation of Rayaldee in Europe, Canada, Mexico, Australia, South Korea and certain other international markets for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) and vitamin D insufficiency.

World Ovarian Cancer Day is May 8 and people across the world are encouraged to raise awareness about ovarian cancer. This year the theme is Know Now and the campaign will run April 25 through May 8.